What is the official website of Amgen ?

The official website of Amgen is http://www.amgen.com.

What is Amgen's cybersecurity risk score?

Amgen has an AI-generated cybersecurity risk score of 796 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Amgen experienced?

According to Rankiteo, Amgen currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Amgen been affected by any supply chain cyber incidents ?

According to Rankiteo, Amgen has been affected by a supply chain cyber incident involving Central Data Storage, with the incident ID AMGCEN1785529893.

Does Amgen have SOC 2 Type 1 certification ?

According to Rankiteo, Amgen is not certified under SOC 2 Type 1.

Does Amgen have SOC 2 Type 2 certification ?

According to Rankiteo, Amgen does not hold a SOC 2 Type 2 certification.

Does Amgen comply with GDPR ?

According to Rankiteo, Amgen is not listed as GDPR compliant.

Does Amgen have PCI DSS certification ?

According to Rankiteo, Amgen does not currently maintain PCI DSS compliance.

Does Amgen comply with HIPAA ?

According to Rankiteo, Amgen is not compliant with HIPAA regulations.

Does Amgen have ISO 27001 certification ?

According to Rankiteo,Amgen is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Amgen operate in ?

Amgen operates primarily in the Biotechnology Research industry.

How many employees does Amgen have ?

Amgen employs approximately 39,570 people worldwide.

Does Amgen own any subsidiaries ?

Amgen presently has no subsidiaries across any sectors.

How many LinkedIn followers does Amgen have ?

Amgen's official LinkedIn profile has approximately 1,661,879 followers.

What is the NAICS classification code for Amgen ?

Amgen is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Amgen have a Crunchbase profile ?

No, Amgen does not have a profile on Crunchbase.

Does Amgen have a LinkedIn profile ?

Yes, Amgen maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/amgen.

How many cybersecurity incidents has Amgen experienced ?

As of August 1, 2026, Rankiteo reports that Amgen has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Amgen have ?

Amgen has an estimated 4,734 peer or competitor companies worldwide.

What types of cybersecurity incidents has Amgen faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Amgen

Boost Score +25 with badge (5 left)

796

/1000

Fair

821

/1000

Good

Amgen Vendor Cyber Rating & Cyber Score

amgen.com

Add Your Compliance Badge

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s

Amgen A.I CyberSecurity Scoring

Scoring History

Amgen

Amgen CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Amgen

Breach

7/2026

Central Data St...

AMGCEN178552989...

Amgen

Breach

4/2021

AMG552072825

Loading…

A.I.

Amgen Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Amgen

Incidents vs Biotechnology Research Industry Avg (This Year)

Amgen has 23.08% fewer incidents than the average of same-industry companies with at least one recorded incident.

Incidents vs All-Companies Average (This Year)

Amgen has 2.91% fewer incidents than the average of all companies with at least one recorded incident.

Incident Types Amgen vs Biotechnology Research Industry Avg (This Year)

Amgen reported 1 incidents this year: 0 cyber attacks, 0 ransomware, 0 vulnerabilities, 1 data breaches, compared to industry peers with at least 1 incident.

Incident History - Amgen (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Amgen Subsidiaries

Amgen

Biotechnology Research

Website: http://www.amgen.com

Company Size: 10,000+ employees

Amgen NetherlandsBiotechnology Research

Amgen DeutschlandBiotechnology

Amgen FranceBiotechnology Research

Amgen OncologyBiotechnology Research

Loading…

Amgen Similar Companies

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Loading…

NEWS

Amgen CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

November 06, 2025 08:00 AM

Why this company says the state of AI security is ‘grim’

Welcome to Eye on AI, with AI reporter Sharon Goldman. In this edition…Mark Zuckerberg and Priscilla Chan have restructured their...

Read Article

July 19, 2024 07:00 AM

Pharma companies report various levels of exposure to IT outage caused by CrowdStrike, Microsoft

Some pharma companies such as Biogen and Amgen said they've been impacted by the CrowdStrike issue, while others like Novo and Lilly...

Read Article

July 18, 2024 07:00 AM

South Asian Heritage Month: Empowering and Enriching Diversity and Community

In celebration of South Asian Heritage Month, Pawandeep Narang, Senior Project Manager, Cybersecurity and Digital Trust, and Global Co-Chair...

Read Article

June 12, 2023 07:00 AM

Investing in the Future: Amgen Welcomes Apprenticeship Participants

Amgen's apprenticeship program provides purpose, opportunity and expands access to diverse talent.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-9044

SUMMARY

An OS command injection vulnerability exists in the VPN module of TP-Link AXE75 V1 routers. This vulnerability allows an adjacent, authenticated attacker to execute arbitrary commands on the device by importing a specially crafted VPN client configuration file. The issue arises from improper filtering of special characters. Successful exploitation of this vulnerability may enable an attacker to gain full control of the affected device, potentially compromising configuration integrity, network security, and service availability.

Published

Date2026-07-31

Updated

Date2026-07-31

RISK INFORMATION (Score: )

cvss4

Base Score: 8.5

Complexity: LOW

CVSS:4.0/AV:A/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:L/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-54909

SUMMARY

pion/stun is a Go implementation of STUN. Prior to 3.1.3, XORMappedAddress.GetFromAs can panic while parsing a malformed short XOR-MAPPED-ADDRESS attribute in STUN or ICE Binding-response parsing paths, allowing remote denial of service. This issue is fixed in version 3.1.3.

Published

Date2026-07-31

Updated

Date2026-07-31

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-54785

SUMMARY

gemini-bridge is a lightweight MCP server bridging AI agents to Google's Gemini AI via the official CLI. From 1.0.0 until 1.3.1, consult_gemini_with_files in inline mode read any file path supplied in the files argument without confining it to the working directory, then forwarded the contents to the Gemini CLI. Because the caller also controls query, the file contents are echoed back through the Gemini round-trip (and sent to Google), making this an arbitrary local file read. This issue is fixed in version 1.3.1.

Published

Date2026-07-31

Updated

Date2026-07-31

RISK INFORMATION (Score: 6.2)

cvss3

Base Score: 6.2

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

2.5

REFERENCES

CVE-2026-54768

SUMMARY

WPGraphQL provides a GraphQL API for WordPress sites. From 2.0.0 until 2.15.1, the deprecated user field on SendPasswordResetEmailPayload lets an unauthenticated caller distinguish existing author-class accounts through the sendPasswordResetEmail mutation and obtain public profile fields. This issue is fixed in version 2.15.1.

Published

Date2026-07-31

Updated

Date2026-07-31

RISK INFORMATION (Score: )

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-53573

SUMMARY

GeoNetwork is a catalog application to manage spatially referenced resources. From 3.12.0 until 4.2.16 and 4.4.11, unsafe redirect validation in GeonetworkOAuth2LoginAuthenticationFilter and KeycloakAuthenticationProcessingFilter permits an attacker-controlled external redirect after login. This issue is fixed in versions 4.2.16 and 4.4.11.

Published

Date2026-07-31

Updated

Date2026-07-31

RISK INFORMATION (Score: )

cvss4

Base Score: 4.8

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:N/VI:N/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…